bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report)’s share price was down 14.6% on Thursday . The company traded as low as $0.2258 and last traded at $0.2258. Approximately 1,400 shares changed hands during mid-day trading, an increase of 14% from the average daily volume of 1,233 shares. The stock had previously closed at $0.2644.
bioAffinity Technologies Stock Performance
The business has a 50 day moving average price of $0.31 and a 200 day moving average price of $0.26.
About bioAffinity Technologies
bioAffinity Technologies, Inc is a clinical-stage medical device company developing an extracorporeal immunoadsorption platform intended to treat Gram-negative sepsis and other severe inflammatory conditions. The company’s technology employs specialized sorbent cartridges designed to selectively bind and remove circulating endotoxins and inflammatory mediators from the bloodstream, with the goal of supporting critical care interventions and improving patient outcomes.
In preclinical studies, bioAffinity’s hemoperfusion devices have demonstrated the ability to capture lipopolysaccharides released by Gram-negative bacteria, leading to reductions in pro-inflammatory cytokines and enhanced survival rates in animal models.
Featured Articles
- Five stocks we like better than bioAffinity Technologies
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- New gold price target
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
